BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 15497162)

  • 21. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Percutaneous ethanol injection (PEI) for small hepatocellular carcinoma].
    Ebara M; Kita K; Nagato Y; Yoshikawa M; Sugiura N; Ohto M
    Gan To Kagaku Ryoho; 1993 May; 20(7):884-8. PubMed ID: 8387759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Percutaneous alcohol administration for hepatocarcinoma: long-term results].
    Lencioni R; Paolicchi A; Bartolozzi C
    Radiol Med; 1997; 94(1-2):8-13. PubMed ID: 9424657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
    Ishii H; Okada S; Nose H; Okusaka T; Nagahama H; Nakayama H; Nakasuka H; Yoshimori M
    Hepatogastroenterology; 1996; 43(10):938-43. PubMed ID: 8884317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous ethanol injection of hepatocellular carcinoma: survival after 3 years in 70 patients.
    Livraghi T
    Ital J Gastroenterol; 1992 Feb; 24(2):72-4. PubMed ID: 1315592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous ethanol injection therapy in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: a long-term result.
    Lin SM; Lin DY; Lin CJ
    Int J Clin Pract; 1999 Jun; 53(4):257-62. PubMed ID: 10563068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.
    Ferrari FS; Stella A; Gambacorta D; Magnolfi F; Fantozzi F; Pasquinucci P; Civeli L; Pieraccini M
    Radiol Med; 2004 Oct; 108(4):356-71. PubMed ID: 15525889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases].
    Levy I; Verstandig A; Sasson T; Wolf D; Krichon I; Libson E; Levensart P; Papo O; Yurim O; Id A; Shouval D
    Harefuah; 2000 Jan; 138(2):89-93, 174. PubMed ID: 10883065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
    Huo TI; Huang YH; Chiang JH; Wu JC; Lee PC; Chi CW; Lee SD
    Scand J Gastroenterol; 2007 Apr; 42(4):485-92. PubMed ID: 17454859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
    Lu DS; Yu NC; Raman SS; Lassman C; Tong MJ; Britten C; Durazo F; Saab S; Han S; Finn R; Hiatt JR; Busuttil RW
    Hepatology; 2005 May; 41(5):1130-7. PubMed ID: 15841454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemoembolization in the therapy of hepatocarcinoma. A 3-year experience].
    Savastano S; Feltrin GP; Miotto D; Chiesura-Corona M; Torraco A; Castellan L; Roman E; el Khatib AB; Cannito F; Sandri P
    Radiol Med; 1992 Nov; 84(5):608-12. PubMed ID: 1335590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Merli M; Nicolini G; Gentili F; Novelli G; Iappelli M; Casciaro G; Di Tondo U; Pecorella I; Marasco A; Onetti Muda A; Nudo F; Mennini G; Ginanni Corradini S; Riggio O; Berloco P; Attili AF; Rossi M
    Transplant Proc; 2005; 37(6):2535-40. PubMed ID: 16182736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
    Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.